By Sahily Paoline, Chief Clinical Officer at Xevant
The prices of prescription drugs in the United States have become a significant obstacle for many individuals seeking access to essential medications. The Office of the Assistant Secretary for Planning and Evaluation shares that the average price increase for drugs from 2016 to 2022 was 31.6%.
The burden of high drug costs often leads to individuals avoiding filling their prescriptions or adhering to prescribed treatment plans, resulting in non-adherence and potentially detrimental health consequences. This article examines the reasons behind this issue, explores potential solutions, and provides advice for readers facing financial difficulties due to drug costs.
